Description: IR-Med Inc., a medical device company, focuses on the development of infra-red (IR) and artificial intelligence technologies to address the diagnosis of common medical ailments. It offers PressureSafe, a non-invasive and real-time optical monitoring device for the preemptive detection of pressure injury; and Nobiotics, an advanced otoscope that works on IR-spectrographic analysis technology providing doctors an immediate indication of the infection being viral or bacterial. The company also engages in developing a real-time noninvasive optical monitor to determine Propofol blood concentration. IR-Med Inc. is based in Rosh Pinna, Israel.
Home Page: www.ir-medical.com
ZHR Industrial Zone
Rosh Pinna,
Israel
Phone:
972 4 655 5054
Officers
| Name | Title |
|---|---|
| Mr. Oded Bashan | Co-Founder & Chairman |
| Mr. Aharon Klein | Co-Founder, CTO & Director |
| Mr. Aharon Binur | Chief Devel. Officer |
| Mr. Moshe Gerber | Chief Exec. Officer |
| Mr. Yaniv Cohen | Co-Founder, R&D Researcher and Director |
| Mr. Sharon Levkoviz | Chief Financial Officer |
| Mr. Yoram Drucker | VP of Bus. Devel. & Director |
| Mr. Avi Vachnis | Head of Software & AI |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 8.3548 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 8 |